English
Zoom-Zoom+Black contrastBlue contrastWhite contrast

How to use the speech recognition tool?

REGENERATE - NCT02407678

REP1 Gene Replacement Therapy for Choroideremia

REP1 Gene Replacement Therapy for Choroideremia

Type: Interventional



Status of the trial: Active, Not recruiting

Orphan Drug Recognition: Yes

Inclusion

  • Opening Date: 2016-08-01
  • Closing Date: 2021-08-01

Criteria

More information

Children: No

Adults: Yes

Funder Type: other


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: